Particles sub-visible (Method 2)

Release analytics and stability studies

Therapeutic Modalities:

Biologics, Cell & Gene Therapies, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.9.19, USP <788>, USP <789>